← Open Payments lookup

KATIE CAIN: Open Payments

NPI 1407697063 · PENSACOLA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$490 in 19 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $455 · 2025 $490

Food & beverage: $490
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.7$154
Novartis Pharmaceuticals Corporation1$104
OPKO Pharmaceuticals, LLC3$50
Ardelyx, Inc.2$49
Vifor Pharma, Inc.2$38
Otsuka Pharmaceutical Development & Commercialization, Inc.1$32
Calliditas Therapeutics US Inc.1$23
Ascendis Pharma Endocrinology Inc1$20
Lilly USA, LLC1$19

Products named: JYNARQUE, Vanrafia, RAYALDEE, IBSRELA, Veltassa, TARPEYO, VOYXACT, Yorvipath.

Industry payments across FL — which companies pay providers there.